Under the Paperwork Reduction Act of 1995 no persons are required to respond to a collection of information unless it displays a valid OMB control number.
PTO Form 1581 (Rev 09/2005) |
OMB No. 0651-0054 (Exp 12/31/2020) |
Request for Extension of Time to File a Statement of Use
(15 U.S.C. Section 1051(d))
The table below presents the data as entered.
Input Field
|
Entered
|
SERIAL NUMBER |
88656051 |
LAW OFFICE ASSIGNED |
LAW OFFICE 125 |
MARK SECTION |
MARK |
ALEVEX (see, http://uspto.report/TM/88656051/mark.png) |
STANDARD CHARACTERS |
YES |
USPTO-GENERATED IMAGE |
YES |
LITERAL ELEMENT |
ALEVEX |
OWNER SECTION (current) |
NAME |
Bayer HealthCare LLC |
MAILING ADDRESS |
100 Bayer Boulevard |
CITY |
Whippany |
STATE |
New Jersey |
ZIP/POSTAL CODE |
07981 |
STATE/COUNTRY/REGION/JURISDICTION/U.S. TERRITORY |
United States |
OWNER SECTION (proposed) |
NAME |
Bayer HealthCare LLC |
MAILING ADDRESS |
100 Bayer Boulevard |
CITY |
Whippany |
STATE |
New Jersey |
ZIP/POSTAL CODE |
07981 |
STATE/COUNTRY/REGION/JURISDICTION/U.S. TERRITORY |
United States |
PHONE |
314-694-6526 |
EMAIL |
XXXX |
CORRESPONDENCE INFORMATION (current) |
NAME |
Sondra Schol |
PRIMARY EMAIL ADDRESS FOR CORRESPONDENCE |
bayertrademarkus@bayer.com |
SECONDARY EMAIL ADDRESS(ES) (COURTESY COPIES) |
NOT PROVIDED |
CORRESPONDENCE INFORMATION (proposed) |
NAME |
Sondra Schol |
PRIMARY EMAIL ADDRESS FOR CORRESPONDENCE |
bayertrademarkus@bayer.com |
SECONDARY EMAIL ADDRESS(ES) (COURTESY COPIES) |
nicole.arendall@bayer.com |
GOODS AND/OR SERVICES SECTION |
INTERNATIONAL CLASS |
003 |
CURRENT IDENTIFICATION |
Non-medicated skin care preparations |
GOODS OR SERVICES |
KEEP ALL LISTED |
INTERNATIONAL CLASS |
005 |
CURRENT IDENTIFICATION |
Preparation for the relief of pain; Topical analgesics; Transdermal patches featuring a nonsteroidal anti-inflammatory for use in treating
pain, headaches, fever, inflammation, common cold symptoms, and joint stiffness; Transdermal patches for use in the treatment of pain, headaches, fever, inflammation, common cold symptoms, and joint
stiffness |
GOODS OR SERVICES |
KEEP ALL LISTED |
EXTENSION SECTION |
EXTENSION NUMBER |
1 |
ALLOWANCE MAIL DATE |
04/28/2020 |
STATEMENT OF USE |
NO |
PAYMENT SECTION |
NUMBER OF CLASSES |
2 |
SUBTOTAL AMOUNT [EXTENSION FEE] |
250 |
TOTAL AMOUNT |
250 |
SIGNATURE SECTION |
SIGNATURE |
/Sondra Schol/ |
SIGNATORY'S NAME |
Sondra Schol |
SIGNATORY'S POSITION |
Senior Assistant General Counsel, Trademarks |
DATE SIGNED |
10/20/2020 |
SIGNATORY'S PHONE NUMBER |
314-694-6526 |
FILING INFORMATION |
SUBMIT DATE |
Wed Oct 21 12:44:52 ET 2020 |
TEAS STAMP |
USPTO/ESU-XXX.XXX.XXX.XXX
-20201021124452451692-886
56051-7502db9fb7e50f37c3d
e9ce12c67b638115d4e3c2db2
e593f6bd8ed3a169c7804d-CC
-44511327-202010201517553
21074 |
Under the Paperwork Reduction Act of 1995 no persons are required to respond to a collection of information unless it displays a valid OMB control number.
PTO Form 1581 (Rev 09/2005) |
OMB No. 0651-0054 (Exp 12/31/2020) |
SOU Extension Request
(15 U.S.C. Section 1051(d))
To the Commissioner for Trademarks:
MARK: ALEVEX (see, http://uspto.report/TM/88656051/mark.png)
SERIAL NUMBER: 88656051
OWNER AND/OR ENTITY INFORMATION
The owner proposes to amend the following:
Current: Bayer HealthCare LLC, having an address of
100 Bayer Boulevard
Whippany, New Jersey 07981
United States
Proposed: Bayer HealthCare LLC, having an address of
100 Bayer Boulevard
Whippany, New Jersey 07981
United States
Phone: 314-694-6526
Fax:
Email: XXXX
The owner requests a six-month extension of time to file the Statement of Use under 37 C.F.R. Section 2.89 in this application. The Notice of Allowance mailing date was 04/28/2020.
For International Class 003:
Current identification: Non-medicated skin care preparations
For a trademark/service mark: The applicant has a continued bona fide intention, and is entitled, to use the mark in commerce on or in connection with all of the goods/services listed in the Notice
of Allowance or as subsequently modified for this specific class; for a collective/certification mark: the applicant has a continued bona fide intention, and is entitled, to exercise legitimate
control over the use of the mark in commerce on or in connection with the goods/services/collective membership organization listed in the Notice of Allowance, or as subsequently modified for this
specific class.
For International Class 005:
Current identification: Preparation for the relief of pain; Topical analgesics; Transdermal patches featuring a nonsteroidal anti-inflammatory for use in treating pain, headaches, fever,
inflammation, common cold symptoms, and joint stiffness; Transdermal patches for use in the treatment of pain, headaches, fever, inflammation, common cold symptoms, and joint stiffness
For a trademark/service mark: The applicant has a continued bona fide intention, and is entitled, to use the mark in commerce on or in connection with all of the goods/services listed in the Notice
of Allowance or as subsequently modified for this specific class; for a collective/certification mark: the applicant has a continued bona fide intention, and is entitled, to exercise legitimate
control over the use of the mark in commerce on or in connection with the goods/services/collective membership organization listed in the Notice of Allowance, or as subsequently modified for this
specific class.
This is the first extension request.
Correspondence Information (current):
Sondra Schol
PRIMARY EMAIL FOR CORRESPONDENCE: bayertrademarkus@bayer.com
SECONDARY EMAIL ADDRESS(ES) (COURTESY COPIES): NOT PROVIDED
Correspondence Information (proposed):
Sondra Schol
PRIMARY EMAIL FOR CORRESPONDENCE: bayertrademarkus@bayer.com
SECONDARY EMAIL ADDRESS(ES) (COURTESY COPIES): nicole.arendall@bayer.com
Requirement for Email and Electronic Filing: I understand that a valid email address must be maintained by the owner/holder and the owner's/holder's attorney, if appointed, and that all
official trademark correspondence must be submitted via the Trademark Electronic Application System (TEAS).
A fee payment in the amount of $250 will be submitted with the form, representing payment for 2 classes.
Declaration
STATEMENTS: The signatory believes that: the applicant has a continued bona fide intention, and is entitled, to use the mark in commerce on or in connection with all the goods/services under Section
1(b) in the notice of allowance or as subsequently modified, or, if applicable, the applicant has a continued bona fide intention, and is entitled, to exercise legitimate control over the use of the
mark in commerce on or in connection with all the goods/services/collective membership organization under Section 1(b) in the notice of allowance or as subsequently modified; and that to the best of
the signatory's knowledge and belief, no other persons, except, if applicable, members and concurrent users, have the right to use the mark in commerce, either in the identical form or in such near
resemblance as to be likely, when used on or in connection with the goods/services/collective membership organization of such other persons, to cause confusion or mistake, or to deceive.
DECLARATION: The signatory being warned that willful false statements and the like are punishable by fine or imprisonment, or both, under 18 U.S.C. §1001, and that such willful false statements and
the like may jeopardize the validity of the application or submission or any resulting registration, declares that all statements made of his/her own knowledge are true and that all statements made
on information and belief are believed to be true.
Signature: /Sondra Schol/ Date Signed: 10/20/2020
Signatory's Name: Sondra Schol
Signatory's Position: Senior Assistant General Counsel, Trademarks
Signatory's Phone: 314-694-6526
RAM Sale Number: 88656051
RAM Accounting Date: 10/21/2020
Serial Number: 88656051
Internet Transmission Date: Wed Oct 21 12:44:52 ET 2020
TEAS Stamp: USPTO/ESU-XXX.XXX.XXX.XXX-20201021124452
451692-88656051-7502db9fb7e50f37c3de9ce1
2c67b638115d4e3c2db2e593f6bd8ed3a169c780
4d-CC-44511327-20201020151755321074